March 27, 2017
Torii Pharmaceutical said on March 24 that it has filed its allergen immunotherapy Miticure House Dust Mite Sublingual Tablets (dermatophagoides farinae extract + dermatophagoides pteronyssinus extract) for its use in children with allergic rhinitis. Miticure is currently approved for patients...read more